Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 11,255 | 727 | 650 | 3,510 | 8,714 |
| Gross Profit | 11,255 | 727 | 650 | 3,510 | 8,714 |
| Operating Expenses | 22,424 | 16,647 | 15,684 | 17,323 | 18,964 |
| Operating Income | -11,169 | -15,920 | -15,034 | -13,813 | -10,250 |
| Other Income | 410 | 314 | 150 | 615 | -479 |
| Pre-tax Income | -10,759 | -15,606 | -14,884 | -13,199 | -10,730 |
| Net Income Continuous | -10,761 | -15,606 | -14,884 | -13,199 | -10,732 |
| Net Income | $-10,761 | $-15,606 | $-14,884 | $-13,199 | $-10,732 |
| EPS Basic Total Ops | -0.11 | -0.18 | -0.18 | -0.18 | -0.15 |
| EPS Basic Continuous Ops | -0.12 | -0.18 | -0.18 | -0.18 | -0.14 |
| EPS Diluted Total Ops | -0.11 | -0.18 | -0.18 | -0.18 | -0.15 |
| EPS Diluted Continuous Ops | -0.12 | -0.18 | -0.18 | -0.18 | -0.14 |
| EBITDA(a) | $-10,140 | $-14,507 | $-13,642 | $-12,564 | $-8,999 |